HOOKIPA PHARMA INC's ticker is HOOK and the CUSIP is 43906K100. A total of 44 filers reported holding HOOKIPA PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $328,511 | -4.7% | 533,113 | +36.0% | 0.00% | – |
Q2 2023 | $344,853 | +19.6% | 391,879 | 0.0% | 0.00% | – |
Q1 2023 | $288,422 | +90884.9% | 391,879 | 0.0% | 0.00% | – |
Q4 2022 | $317 | -99.9% | 391,879 | -0.2% | 0.00% | – |
Q3 2022 | $526,000 | -17.8% | 392,825 | 0.0% | 0.00% | – |
Q2 2022 | $640,000 | -10.6% | 392,825 | +25.0% | 0.00% | – |
Q1 2022 | $716,000 | -18.4% | 314,337 | -16.5% | 0.00% | – |
Q4 2021 | $877,000 | -63.3% | 376,476 | -7.1% | 0.00% | – |
Q3 2021 | $2,387,000 | -31.4% | 405,421 | +6.8% | 0.00% | – |
Q2 2021 | $3,478,000 | -23.7% | 379,702 | +12.0% | 0.00% | -100.0% |
Q1 2021 | $4,561,000 | +152.3% | 339,130 | +108.0% | 0.00% | – |
Q4 2020 | $1,808,000 | +30.4% | 163,079 | +11.4% | 0.00% | – |
Q3 2020 | $1,386,000 | -16.9% | 146,366 | +2.0% | 0.00% | – |
Q2 2020 | $1,667,000 | +83.6% | 143,520 | +30.3% | 0.00% | – |
Q1 2020 | $908,000 | -63.8% | 110,152 | -46.3% | 0.00% | – |
Q4 2019 | $2,508,000 | +531.7% | 205,162 | +287.1% | 0.00% | – |
Q3 2019 | $397,000 | +242.2% | 53,001 | +206.4% | 0.00% | – |
Q2 2019 | $116,000 | – | 17,296 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 1,842,902 | $17,452,000 | 0.32% |
Samsara BioCapital, LLC | 116,602 | $1,104,000 | 0.31% |
Artal Group S.A. | 599,616 | $5,678,000 | 0.14% |
HHLR ADVISORS, LTD. | 943,254 | $8,933,000 | 0.07% |
DAFNA Capital Management LLC | 22,061 | $209,000 | 0.07% |
Baker Brothers Advisors | 700,481 | $6,634,000 | 0.03% |
ZACKS INVESTMENT MANAGEMENT | 72,064 | $682,000 | 0.01% |
HOWLAND CAPITAL MANAGEMENT LLC | 14,728 | $139,000 | 0.01% |
ETF MANAGERS GROUP, LLC | 14,374 | $139,000 | 0.00% |
Squarepoint Ops LLC | 12,699 | $120,000 | 0.00% |